A review of ketamine’s role in ECT and non-ECT settings

References

• MrazekDAHornbergerJCAltarCADegtiarIA review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013Psychiatr Serv201465897798724789696
   PubMed Web of Science ®Google Scholar
• IncSCProduct MonographQC, CanadaSandoz Canada Inc.2015 Available from: https://www.sandoz.ca/sites/www.sandoz.ca/files/Ketamine_HCl_PMe_20150506.pdfAccessed July 13, 2017
   Google Scholar
• NaughtonMClarkeGO’LearyOFCryanJFDinanTGA review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of actionJ Affect Disord2014156243524388038
   PubMed Web of Science ®Google Scholar
• NewportDJCarpenterLLMcDonaldWMKetamine and other NMDA antagonists: early clinical trials and possible mechanisms in depressionAm J Psychiatry20151721095096626423481
   PubMed Web of Science ®Google Scholar
• SanacoraGFryeMAMcDonaldWA consensus statement on the use of ketamine in the treatment of mood disordersJAMA Psychiatry201774439940528249076
   PubMed Web of Science ®Google Scholar
• KennedySHLamRWMcIntyreRSCanadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatmentsCan J Psychiatry201661954056027486148
   PubMed Web of Science ®Google Scholar
• JarventaustaKChrapekWKampmanOEffects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot studyJ ECT201329315816123475029
   PubMed Web of Science ®Google Scholar
• WangXChenYZhouXLiuFZhangTZhangCEffects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorderJ ECT201228212813222622291
   PubMed Web of Science ®Google Scholar
• YalcinSAydoganHSelekSKetofol in electroconvulsive therapy anesthesia: two stones for one birdJ Anesth201226456256722623080
   PubMed Web of Science ®Google Scholar
• YoosefiASepehriASKargarMComparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind studyJ ECT2014301152124091902
   PubMed Web of Science ®Google Scholar
• AbdallahCGFasulaMKelmendiBSanacoraGOstroffRRapid antidepressant effect of ketamine in the electroconvulsive therapy settingJ ECT201228315716122847373
   PubMed Web of Science ®Google Scholar
• ErdilFOzgulUColakCCumurcuBDurmusMEffect of the addition of ketamine to sevoflurane anesthesia on seizure duration in electroconvulsive therapyJ ECT201531318218525719444
   PubMed Web of Science ®Google Scholar
• SalehiBMohammadbeigiAKamaliARTaheri-NejadMRMoshiriIImpact comparison of ketamine and sodium thiopental on anesthesia during electroconvulsive therapy in major depression patients with drug-resistant; a double-blind randomized clinical trialAnn Card Anaesth201518448649026440233
   PubMedGoogle Scholar
• RybakowskiJKBodnarAKrzywotulskiMKetamine anesthesia, efficacy of electroconvulsive therapy, and cognitive functions in treatment-resistant depressionJ ECT201632316416827008330
   PubMed Web of Science ®Google Scholar
• AndersonIMBlamireABrantonTRandomised controlled trial of ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT study)Efficacy Mech Eval201742
   Google Scholar
• KuscuOOKaracaerFBiricikEGulecETamamLGunesYEffect of ketamine, thiopental and ketamine-thiopental combination during electroconvulsive therapy for depressionTurk J Anaesthesiol Reanim201543531331727366520
   PubMedGoogle Scholar
• FernieGCurrieJPerrinJSKetamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trialBr J Psychiatry2017210642242828254962
   PubMed Web of Science ®Google Scholar
• ZhongXHeHZhangCMood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depressionJ Affect Disord201620112413027208499
   PubMed Web of Science ®Google Scholar
• RasmussenKGKungSLapidMIA randomized comparison of ketamine versus methohexital anesthesia in electroconvulsive therapyPsychiatry Res2014215236236524388729
   PubMed Web of Science ®Google Scholar
• LooCKKatalinicNGarfieldJBSainsburyKHadzi-PavlovicDMac-PhersonRNeuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trialJ Affect Disord20121421–323324022858219
   PubMed Web of Science ®Google Scholar
• ErdilFBegecZKayhanGEYologluSErsoyMODurmusMEffects of sevoflurane or ketamine on the QTc interval during electroconvulsive therapyJ Anesth201529218018525085036
   PubMed Web of Science ®Google Scholar
• KudohATakahiraYKatagaiHTakazawaTSmall-dose ketamine improves the postoperative state of depressed patientsAnesth Analg200295111411812088953
   PubMed Web of Science ®Google Scholar
• LenzeEJFarberNBKharaschENinety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trialWorld J Biol Psychiatry201617323023826919405
   PubMed Web of Science ®Google Scholar
• LiCTChenMHLinWCThe effects of low-dose ketamine on the prefrontal cortex and amygdala in treatment-resistant depression: a randomized controlled studyHum Brain Mapp20163731080109026821769
   PubMed Web of Science ®Google Scholar
• IbrahimLDiazgranadosNFranco-ChavesJCourse of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4-week, double-blind, placebo-controlled studyNeuropsychopharmacology20123761526153322298121
   PubMed Web of Science ®Google Scholar
• MathewSJMurroughJWaan het RotMCollinsKAReichDLCharneyDSRiluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trialInt J Neuropsychopharmacol2010131718219288975
   PubMed Web of Science ®Google Scholar
• HuYDXiangYTFangJXSingle i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week studyPsychol Med201646362363526478208
   PubMed Web of Science ®Google Scholar
• JafariniaMAfaridehMTafakhoriAEfficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: a double-blind, randomized, controlled trialJ Affect Disord20162041827317968
   PubMed Web of Science ®Google Scholar
• DalyEJSinghJBFedgchinMIntranasal esketamine in treatment resistant depression – a double-blind, randomized, efficacy and dose response studySociety of Biological Psychiatry’s (SOBP) 71st Annual MeetingMay 12–14, 2016Atlanta, GA, USA
   Google Scholar
• CanusoCSinghJFedgchinMA novel study design to evaluate the rapid reduction of the symptoms of major depressive disorder, including suicidal ideation, in subjects assessed to be at imminent risk for suicideNeuropsychopharmacology20154022S480
   Google Scholar
• ZanosPGouldTDIntracellular signaling pathways involved in (S)- and (R)-ketamine antidepressant actionsBiol Psychiatry20188312429173705
   PubMed Web of Science ®Google Scholar
• Drug Safety FDA CommunicationFDA review results in new warnings about using general anesthetics and sedation drugs in young children and pregnant women issued on December 14, 2016Safety Announcement [4-27-2017]2017 Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/UCM554644.pdfAccessed September 1, 2017
   Google Scholar
• NiciuMJLuckenbaughDAIonescuDFClinical predictors of ketamine response in treatment-resistant major depressionJ Clin Psychiatry2014755e417e42324922494
   PubMed Web of Science ®Google Scholar
• NiciuMJLuckenbaughDAIonescuDFKetamine’s antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorderInt J Neuropsychopharmacol2014181ii
   Web of Science ®Google Scholar
• IonescuDFLuckenbaughDANiciuMJEffect of baseline anxious depression on initial and sustained antidepressant response to ketamineJ Clin Psychiatry2014759e932e93825295436
   PubMed Web of Science ®Google Scholar
• MurroughJWBurdickKELevitchCFNeurocognitive effects of ketamine and association with antidepressant response in individuals with treatment-resistant depression: a randomized controlled trialNeuropsychopharmacology20154051084109025374095
   PubMed Web of Science ®Google Scholar
• SunLLiQLiQChronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeysAddict Biol201419218519423145560
   PubMed Web of Science ®Google Scholar
• ShelineYINeuroimaging studies of mood disorder effects on the brainBiol Psychiatry200354333835212893109
   PubMed Web of Science ®Google Scholar
• FournierJCDeRubeisRJHollonSDAntidepressant drug effects and depression severity: a patient-level meta-analysisJAMA20103031475320051569
   PubMed Web of Science ®Google Scholar